Explore more publications!

Vigna Law Group: Depo-Provera Meningioma Claim Filed in Alameda County, California

Dr. Greg Vigna

Dr. Greg Vigna

Case: 25CV151521

Medical literature links continued Depo-Provera use after meningioma resection to higher recurrence, raising physician and manufacturer liability concerns

We filed this case because drug was not only prescribed before our client's meningioma diagnosis, but also continued after surgical removal of the tumor.”
— Greg Vigna, MD, JD

LOS ANGELES, CA, UNITED STATES, January 7, 2026 /EINPresswire.com/ -- “At some point, physicians can be held liable for prescribing Depo-Provera when there are alternative birth control medications that do not cause mutations that lead to brain tumors. The literature on this is clear,” states Greg Vigna, MD, JD, national malpractice, Depo-Provera attorney.

Dr. Greg Vigna, MD, JD, says, “We filed this case because drug was not only prescribed before our client's meningioma diagnosis, but also continued after surgical removal of the tumor. We allege that our client’s injuries were further exacerbated by the ongoing prescription, resulting in additional harm." (Case: 25CV151521, Superior Court of the State of California for the County of Alameda).

Dr. Vigna continues, “Clearly, women who are newly diagnosed and have a history of recent use should have their cases closely reviewed to determine whether their claims may be more appropriately filed against both the prescribing physician and the manufacturer of Depo-Provera or an authorized generic in state court where the injury occurred.“

What does the literature say about continued use of Depo-Provera after resection?

Read Dr. Tessa Harland's report in “Progesterone-only contraception is associated with a shorter progression-free survival in premenopausal women with WHO Grade I meningioma” published in the Journal of Neuro-oncology (2018) 136:327-333?:

"Compared to patients taking combination or estrogen-only contraception, those taking progesterone-only contraception demonstrated a greater recurrence rate (33.3 vs. 19.6%) with a reduced time to recurrence (18 vs. 32 months, p = 0.038) … those taking progesterone-only contraception.”

Read Dr. Harland’s article here.

Dr. Vigna concludes, “There have always been safer medications for contraception than Depo-Provera. This is a drug that causes specific mutations to women’s DNA."

Watch Dr. Vigna’s educational episode on Justice with Dr. V for an in-depth look at the association of Depo-Provera and Meningiomas.

Click here to watch Justice with Dr. V on Tik Tok to learn more on Depo-Provera.

Dr. Vigna is a California and Washington DC lawyer and is Co-Counsel with the Ben Martin Law Group, a national pharmaceutical injury law firm in Dallas, Texas. The attorneys are product liability and medical malpractice attorneys, and they represent women who have suffered meningiomas.

To learn more, visit https://vignalawgroup.com/practice-area/meningioma-resection/.

Case: 25CV151521
Superior Court of the State of California for the County of Alameda


California Offices:
8939 S. Sepulveda Blvd., Suite 102, Los Angeles, CA 90045
2570 N. First Street,2nd Floor, San Jose, CA 95131
931 10th Street, #962, Modesto, CA 95354
2281 Lava Ridge Court, Suite 200, Roseville, CA 95661
600 West Broadway, Suite 700, San Diego, CA 92101

Connecticut Office:
515 Centerpoint Drive, Suite #2212, Middletown, CT 06457

Greg Vigna, MD, JD
Vigna Law Group
+1 817-809-9023
email us here
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions